Author: kwm107
-
Cosmetic Complaints Climb, But Products Still on Market
Consumer complaints for cosmetic products have more than doubled, but consumers may remain at risk because the industry receives little regulatory scrutiny, according to new research.
-
Poxvirus Yields New Insights into Protein Synthesis
Northwestern Medicine scientists studied a poxvirus and demonstrated that ribosomes can selectively control the process of protein synthesis known as translation.
-
Student and Resident Receive AMA Excellence in Medicine Awards
Quentin Youmans, MD, a second-year resident in internal medicine, received the Leadership Award, and Elsy Compres, a second-year medical student, received the Minority Scholars Award from the American Medical Association Foundation.
-
Mechanism Behind Insensitivity to Pain Discovered
A new study explains how mutations in a sodium channel can lead to a disorder causing insensitivity to pain.
-
Faculty Elected to Prominent Medical Societies
Three faculty members were recently inducted into two prestigious organizations, the American Society for Clinical Investigation and the Association of American Physicians.
-
3-D Printed Ovaries Produce Healthy Offspring
Bioprosthetic ovaries produced using 3-D printing allowed otherwise infertile mice to successfully give birth to healthy mouse pups.
-
Weekly Steroids Strengthen and Repair Muscles
Weekly doses of glucocorticoid steroids, such as prednisone, help speed recovery in muscle injuries and repair muscles damaged by muscular dystrophy, according to a study.
-
Student Studies the Roots of Glioblastoma
Read a Q-and-A with Jasmine May, a fifth-year student in the Medical Scientist Training Program, who studies the pathophysiology of glioblastoma.
-
Leaving Segregated Neighborhoods Reduces Blood Pressure for Blacks
Systolic blood pressure for African-American patients dropped between one to five points when they moved to less segregated neighborhoods, according to a new study.
-
First Spherical Nucleic Acid Drug Injected into Humans Targets Brain Cancer
The first drug using spherical nucleic acids to be systemically given to humans has been developed by Northwestern University scientists and approved by the Food and Drug Administration as an investigational new drug for an early-stage clinical trial in the deadly brain cancer glioblastoma multiforme.
